Business
Conavi Medical Highly Encouraged by New U.S. Intracoronary Guidelines
– IVUS and OCT cited as playing essential and complementary roles, validating Novasight&#x...
About this update from Conavi Medical Corp.
[{"type":"text","content":"Conavi Medical Highly Encouraged by New U.S. Intracoronary Guidelines\n\n\n\n – IVUS and OCT cited as playing essential and complementary roles, validating Novasight’s unique hybrid imaging capability\n \n\n – Guidelines constitute strong recommendations based on the highest level of evidence\n \n\n – Clinical data show intracoronary imaging leads to lower risk of target vessel failure (including cardiac death) in coronary procedures\n \n\n – Company anticipates similar changes to other guidelines covering coronary procedures\n \n\n TORONTO, March 04, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI; OTC: CNVIF) (“\n \n Conavi Medical\n \n ” or the “\n \n Company\n \n ”), a commercial stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, responded today to new intracoronary imaging guidelines by the American College of Cardiology, American Heart Association and other medical organizations. The guidelines apply to patients presenting with acute coronary syndrome (ACS) and undergoing a coronary intervention in the left main artery or complex lesions. Notably, the guidelines are rated Class 1A, indicating the highest level of evidence and strongest level of recommendation.\n \n\n The new guidelines offer strong validation for Conavi as the only provider of hybrid IVUS (ultrasound) and OCT (optical) imaging technology. As the authors explain, “both IVUS and OCT play essential roles in evaluating the necessity for lesion preparation, choosing the appropriate stent size, reducing the likelihood of geographical errors, confirming proper stent expansion, identifying complications, and determining the underlying reasons for stent failure.”\n \n\n \"The updated guidelines reaffirm the critical role of intracoronary imaging in optimizing stent procedures and improving patient outcomes,\" said Dr. Megha Prasad, an interventional cardiologist. \"By leveraging the advantages of both IVUS and OCT, we can enhance precision in stent placement, minimize complications, and ultimately optimize care for patients with complex coronary artery disease. Conavi’s Novasight system, as the only hybrid IVUS-OCT device, uniquely equips physicians with both ima...